Ekf Diagnostics Share Discussion Threads

[stupidboypike] 02/2/2015 14:58

Cisk, hope you're right but as you point out cash is getting very tight. If turnover is growing at very rapid rate then cash may well be required for working capital purposes. Not a bad thing in it's own right but obviously likely to be negative for the share price in the short term. Anyway I guess we will know in the next few weeks. Best regards SBP

[cisk] 02/2/2015 14:32

Pike, I would be both surprised and annoyed if this were true, if they aren't doing any acquisitions this year then why do they need the money?

Net cash at year end was down to £2.4m from £5.2m at the half year - so looks like they are burning through just under half a mil per month; I note that debtors increased considerably so possibly working capital is tight? Also not sure when £1.4m is payable as final consideration for Diaspect.

On the face of it they have maybe 6 months at the current run rate before net cash is zero; we all would hope that they bring in more business before then.

I doubt that they would be able to get a placing to fly on the back of working capital purposes, besides there's no way any more shares should be issued if no deals are done.

They need to hunker down, get everything working and build profits. Judging from the TU last week, management have got the message (we hope).

[wan] 02/2/2015 14:02

With a suggestion like that....don't tell them your name Pike!

[stupidboypike] 02/2/2015 13:43

Call me cynical, but doesn't change of advisor normally mean, "placing on the way" ? I have these on my watch list and I do think they will come good over the next couple of years but I will wait and see if my placing suggestion has any legs before dipping my toe in.

Best regards SBP

[busterdog2] 30/1/2015 16:06

From todays Times...

On Aim, EKF Diagnostics eased by 9.1 per cent to 20½p a day after a bullish trading update. N+1 Singer, traders reported, had taken out two chunky sellers of the healthcare company’s shares.

[totaleclipse] 29/1/2015 16:53

Always makes me nervous when huge trades at the sell price go through late in the day. Can't help wondering 'what do they know that I don't'

[totaleclipse] 29/1/2015 16:43

Ten million shares traded???? According to LSE

[andrewbaker] 28/1/2015 13:42

I think that the stock overhang may now be in the past, or close to in the past, and the true value of the company's business may now be better appreciated through its share price. The recent news is good, and hopefully so will future news; such that the share price may in future properly reflect the potential that is there. This is one smaller company that I hold, and will continue so to do for the foreseeable future.

[wan] 28/1/2015 09:33

Cisk...I have only taken a small bite (at this stage), the management have listened to shareholders and adjusted to what looks a better strategy of purely focusing on and sweating the existing assets. Encouragingly the management now appear confident in achieving significant 'organic' growth,let's judge them accordingly!

In the short to medium term there are some interesting and potentially catalyst updates in the pipeline, which in my opinion could reverse the trend and push the shares well above 25p.

[cisk] 28/1/2015 09:14

Wan, good to see you here as well as on the AVCT board.

Must admit after attending the last presentation given by the management, they seemed to have a lot to do for the year end; they mentioned a handful of contracts, which, if won, would make a material difference toward the year end numbers.

Reading through the narrative today, it seems like these are still in the pipeline, so they must have had a stonking year end to bring the numbers up.

Also it looks like the deferred consideration for Selah won't now be paid, and it's a huge amount in the context of the market cap.

All the indications are that 2015 will be a good year for them - I guess it's probably going to take 2 years more than I originally hoped.

[totaleclipse] 28/1/2015 08:44

Brilliant results. Especially in the face of tough conditions in Russia. Glad I hung on.

[wan] 28/1/2015 08:17

Interesting and encouraging update and worthy of me dipping my toe back in here.

[sikhthetech] 22/1/2015 10:31

Hi Garth,

can we please have your assistance on the Pace thread?

thanks...

[garth] 20/1/2015 08:54

Currently valued at £100m if you include the debt - according to ADVN's notoriously reliable quick figures... They raised over £20 million last year from investors.

Andrew et al, the share price has dropped below 4 year lows and continues to fall. On a share price chart level a change in sentiment could possibly bring a 50% rise. But at £100 million, what makes these good value?

Comments appreciated.

G.

[mach100] 19/1/2015 12:40

And cheaper again today.I suppose having a stake in Russia is not helpful given the situation in Ukraine.It does seem to find support around this level but wonder if it might fall through support this time. An interesting share but it hasn't done well its acquisitions in terms of managing and integration.

[andrewbaker] 09/1/2015 16:53

This is getting more tempting by the day. I already hold a goodly number, and buying more would make it a tad top heavy in the overall portfolio, so I'll bide my time until a new uptrend is in place; but for those without a sizeable holding already, the current offer price is compelling, IMHO.

[croasdalelfc] 08/1/2015 16:42

EKF Diagnostic Holdings (EKF) has kept its "buy" rating from Canaccord Genuity following the renegotiation of the earn-out terms for its acquisition of DiaSpect Medical. The revised deal reduces the total payments involved in the purchase from 4.25 million pounds to 1.425 million pounds. Canaccord has maintained its target price of 30p and said that it was looking forward to fresh details on a number of deals being released in the coming weeks from the diagnostic instruments business. EKF shares climbed by 0.25p to 21.25p.

[totaleclipse] 06/1/2015 17:11

Croas... not sure....if they weren't selling as expected then better to leave things as they were as less earn out is payable. But someone benefitting from the earn out (an ex Diaspect shareholder) may want to liquidate their position early for other reasons- a bit like cashing in an accumulator bet early. Well that's the way I see it.

[croasdalelfc] 05/1/2015 19:53

EKF 'save' themselves potentially £3.225 m with this announcement. Presumably Diaspect is not selling as well as expected. -- additional, deferred consideration, based on certain milestone targets being achieved, over eight milestone payments across a four year period, of up to GBP4,750,000 in aggregate, which will be satisfied by the payment of additional cash ("DiaSpect Deferred Consideration"),

[totaleclipse] 01/1/2015 12:32

Happy New Year one and all- let's hope the preliminary results for the year are a little improved on what has been suggested. 4

[rambutan2] 18/12/2014 17:56

I thought this the most interesting bit of the update...

As announced on 11 November 2014 Ron Zwanziger, founder and ex-CEO of Alere Inc., has established a significant shareholding in the Company. Discussions are ongoing with a view to him joining the Board in the near future as Non-Executive Chairman. David Evans would remain on the Board as Executive Deputy Chairman. A further announcement will be made regarding the prospective appointment in due course.

Why did RZ choose to get involved with the likes of EKF? I am intrigued and would have thought that his buy in price of 26-27p is worth remembering.

[fillipe] 18/12/2014 17:39

Pug - yes, 422m shrs. i see the consensus of 3 brokers if for eps of 1.06p for the year to 12/2015.

Mkt cap at 20p is over £84m and that seems still a lot too high, given the uncertainties et al, here.

f

[pugugly] 18/12/2014 16:00

Number of shares issued in ADVFN fundamentals very wrong - Should be(m) 422.06.

Placing and open offer not yet added to previous number issue.

Therefore all other stats wrong especially market cap, p/e and eps - Position far worse than data on Quote and finacial pages.

eps now likely (brokers forecasts) to be negative for foreseeable (fy 16 estimates) .

[totaleclipse] 17/12/2014 15:49

I agree- fall overdone. I've bought some more today in my ISA to protect the lovely capital gains that are going to come next year.